Cabot Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Cabot Wealth Management's LLY Position: Q1 2026 in Review
Cabot Wealth Management reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $176K and leaving 8,200 shares worth $7.54M. The position accounts for 0.87% of the portfolio, ranked #43.
Cabot Wealth Management first reported a position in LLY in Q3 2018 and has held it in 31 quarters since. The position peaked at $9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Cabot Wealth Management held 8,200 shares of Eli Lilly worth $7.54M as of Q1 2026.
- Cabot Wealth Management sold 174 Eli Lilly shares in Q1 2026, an estimated $176K.
- Eli Lilly made up 0.87% of Cabot Wealth Management's portfolio in Q1 2026, its #43 holding.
- Cabot Wealth Management first reported a position in Eli Lilly in Q3 2018 and has held it in 31 quarters since.
- Cabot Wealth Management's Eli Lilly position peaked at $9M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Cabot Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.